+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biological Implants Market by Orthopedic Implants, Cardiovascular Implants, Dental Implants, Spinal Implants, Neurological Implants, Ocular Implants - Global Forecast to 2030- Product Image
Biological Implants Market by Orthopedic Implants, Cardiovascular Implants, Dental Implants, Spinal Implants, Neurological Implants, Ocular Implants - Global Forecast to 2030- Product Image
Sale

Biological Implants Market by Orthopedic Implants, Cardiovascular Implants, Dental Implants, Spinal Implants, Neurological Implants, Ocular Implants - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011394
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biological Implants Market grew from USD 40.90 billion in 2024 to USD 49.91 billion in 2025. It is expected to continue growing at a CAGR of 21.42%, reaching USD 131.13 billion by 2030.

Exploring the Frontiers of Biological Implant Innovation

The biological implants market stands at the forefront of medical innovation, driving unprecedented advances in patient care across diverse therapeutic areas. As population demographics shift and chronic conditions become more prevalent, the demand for durable, biocompatible solutions is accelerating. This executive summary distills the latest industry developments to provide a clear understanding of technological breakthroughs, evolving regulatory frameworks, and emerging market dynamics. Decision-makers will find a concise yet comprehensive overview, crafted to facilitate strategic planning and investment prioritization.

Drawing on rigorous primary interviews with leading clinicians and industry executives, as well as exhaustive secondary research from authoritative public and proprietary sources, this summary offers an actionable snapshot of current trends. It highlights critical inflection points, from the adoption of novel biomaterials to shifts in global supply chains. By synthesizing complex data into digestible insights, this introduction sets the stage for a deeper exploration of segment-specific growth opportunities, regional nuances, and competitive imperatives that define the biological implants arena.

Pioneering Paradigm Shifts Reshaping the Biological Implant Arena

Over the past decade, the biological implants sector has undergone transformative shifts fueled by breakthroughs in advanced manufacturing, biomaterials science, and digital health integration. Additive manufacturing platforms now enable patient-specific prostheses with unprecedented anatomical precision, while next-generation polymer and ceramic composites enhance osseointegration and long-term performance. Concurrently, the integration of sensors and wireless connectivity is ushering in a new era of “smart” implants capable of real-time monitoring and adaptive therapy.

Regulatory agencies are adapting to these innovations, establishing accelerated pathways and harmonized guidelines that reduce time to market without compromising safety. Patient-centric design philosophies are gaining prominence, driven by feedback loops between clinicians, engineers, and end users. These cumulative shifts are redefining research priorities, driving cross-disciplinary collaboration and unlocking fresh value pools across orthopedics, cardiovascular, dental, spinal, neurological, and ocular applications.

Tariff Tide: Navigating U.S. Duties Impacting Implant Dynamics

In 2025, the United States introduced a revised tariff regime impacting key components and raw materials utilized in biological implant manufacturing. This recalibration of duties has precipitated a notable increase in import costs for medical-grade titanium, cobalt-chrome alloys, and specialized polymers. As a result, manufacturers are recalibrating their sourcing strategies, exploring alternative suppliers in low-tariff jurisdictions, and negotiating supplier consortia agreements to mitigate price volatility.

The cumulative effect of these duties has varied across device categories. High-volume producers of orthopedic implants are absorbing incremental costs through lean manufacturing initiatives, whereas smaller innovators are evaluating partial onshore production or forging strategic partnerships to secure stable supply. Despite initial margin pressure, many established and emerging players anticipate leveraging scale efficiencies and localized production to restore competitive positioning by year-end.

Decoding Market Segments to Uncover Growth Opportunities

Segment analysis reveals that orthopedic implants retain the lion’s share of market activity, with joint replacement procedures-particularly in hip, knee, and shoulder applications-continuing to drive revenue growth. Osteosynthesis solutions, encompassing bone plates and screws, and trauma fixation devices, including external fixators, intramedullary nails, and combined plate-screw constructs, are also exhibiting robust demand as minimally invasive surgical techniques gain acceptance. In parallel, cardiovascular implants are benefiting from rising prevalence of heart disease and peripheral vascular disorders, where mechanical and tissue heart valves, bare metal and drug-eluting stents, and a diverse array of vascular grafts form a comprehensive continuum of care.

Dental implants remain a steadfast pillar of the broader market, with endosseous designs in blade form and root form leading adoption, alongside subperiosteal and zygomatic options for complex anatomies. Spinal segment technologies-including disc replacement solutions, plates, screws and rods for fixation, and fusion devices such as bone graft substitutes and cages-are advancing through modular instrument sets and biologically active coatings. Neurological implant innovation is centered on deep brain stimulators in adaptive and fixed-rate configurations, spinal cord stimulators in paddle and percutaneous formats, and vagal nerve stimulators optimized for epilepsy and mood disorder indications. Finally, ocular implants, spanning monofocal, multifocal, and toric intraocular lenses as well as epiretinal and subretinal devices, are leveraging microfabrication techniques to refine visual outcomes.

Regional Forces Driving Diverse Implant Market Trajectories

The Americas region continues to command a leading position, driven by established reimbursement frameworks, high per-capita healthcare expenditure, and a strong network of clinical research sites that foster rapid adoption of breakthrough implants. Market players in North and Latin America are capitalizing on post-pandemic procedural backlogs and expanding outpatient surgical centers to accelerate volumes.

Europe, Middle East & Africa displays heterogeneous growth patterns, where Western Europe maintains steady uptake through legacy healthcare infrastructure and centralized procurement, while emerging markets in the Gulf Cooperation Council and Sub-Saharan Africa present nascent opportunities for cost-effective implant solutions and technology transfers. Strategic alliances between local distributors and global original equipment manufacturers are pivotal to navigating regulatory variances and facilitating market entry.

Asia-Pacific exhibits the highest CAGR potential, fueled by aging populations in Japan and China, escalating government investment in domestic manufacturing capabilities, and expanding private healthcare networks in India and Southeast Asia. Increasingly, regional OEMs are adopting lean production models to compete on price and quality, reshaping the competitive topology.

Leading Innovators Shaping the Competitive Landscape

The competitive landscape is anchored by industry stalwarts and agile challengers investing heavily in R&D, M&A, and collaborative ventures. Leading orthopedic and spinal device manufacturers are expanding into biologics and additive manufacturing through acquisitions of startups and minority equity stakes. Cardiovascular innovators are forging partnerships with contract research organizations and tech firms to develop next-generation sensor-embedded stents and valve systems.

Dental implant leaders are deepening clinician networks and launching digital planning platforms that integrate seamlessly with chairside workflows, while neurological implant pioneers are securing regulatory approvals across major markets to broaden their pipeline. Ocular device companies are heavily focused on premium intraocular lens offerings and exploring gene therapy adjuncts, reflecting a convergence of device and biologic modalities. Across all categories, platform extensions and software-driven service models are distinguishing market leaders.

Strategic Actions to Capitalize on Emerging Implant Trends

To thrive in this dynamic environment, industry leaders should prioritize the integration of advanced biomaterials with digital feedback loops that enhance post-operative monitoring. Establishing risk-sharing agreements with payers for high-value devices can accelerate market access, while investing in local manufacturing hubs will mitigate tariff exposure and shorten lead times. Alliances with academic centers and multidisciplinary consortia will catalyze early validation of novel therapies and drive regulatory alignment.

Leaders must also tailor go-to-market strategies to regional idiosyncrasies, deploying differentiated pricing models and modular product offerings to address affordability challenges in emerging economies. Cultivating a talent pool proficient in data science, regulatory affairs, and human-centered design will underpin sustained innovation. By embracing these imperatives, companies can transform market volatility into a strategic advantage.

Rigorous Methodology Ensuring Insightful Market Analysis

This analysis is grounded in a robust methodology combining primary research-comprising in-depth interviews with surgeons, procurement specialists, and device engineers-with secondary data synthesized from peer-review journals, regulatory filings, and proprietary databases. Qualitative insights were triangulated with quantitative metrics to ensure consistency and validity across product categories and regions.

Segmentation definitions were aligned with international classification standards, while tariff impact assessments leveraged trade‐flow data and customs records. Forecasts were excluded to maintain an unbiased view of current market forces. Rigorous peer review and editorial audits were conducted to uphold analytical rigor and factual accuracy, ensuring that stakeholders can rely on these insights to inform strategic decisions.

Synthesis of Insights Guiding Stakeholder Decisions

The confluence of technological innovation, evolving regulatory landscapes, and shifting geopolitical dynamics underscores the complexity and promise of the biological implants market. Orthopedic and cardiovascular segments remain foundational, while emerging domains in neurostimulation and ocular implants are poised for rapid advancement. Regional disparities require nuanced approaches, and tariff adjustments demand proactive supply chain realignment.

Companies that align R&D investments with patient-centric design principles, engage payers through value-based models, and cultivate flexible manufacturing footprints will be best positioned to capture growth. As the market continues to mature, collaborative ecosystems spanning academia, industry, and government will drive the next wave of breakthroughs. This executive summary provides a strategic compass for stakeholders seeking to navigate the path forward.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Orthopedic Implants
    • Joint Replacement
      • Hip Replacement
      • Knee Replacement
      • Shoulder Replacement
    • Osteosynthesis
      • Bone Plates
      • Bone Screws
    • Trauma Fixation
      • External Fixators
      • Intramedullary Nails
      • Plates And Screws
  • Cardiovascular Implants
    • Heart Valves
      • Mechanical
      • Tissue
    • Stents
      • Bare Metal
      • Drug Eluting
    • Vascular Grafts
  • Dental Implants
    • Endosseous Implants
      • Blade Form
      • Root Form
    • Subperiosteal Implants
    • Zygomatic Implants
  • Spinal Implants
    • Disc Replacement
    • Spinal Fixation
      • Plates
      • Screws And Rods
    • Spinal Fusion Devices
      • Bone Graft Substitutes
      • Cages
  • Neurological Implants
    • Deep Brain Stimulators
      • Adaptive
      • Fixed Rate
    • Spinal Cord Stimulators
      • Paddle
      • Percutaneous
    • Vagal Nerve Stimulators
  • Ocular Implants
    • Intraocular Lenses
      • Monofocal
      • Multifocal
      • Toric
    • Retinal Implants
      • Epiretinal
      • Subretinal
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Smith & Nephew plc
  • Becton, Dickinson and Company
  • Globus Medical, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biological Implants Market, by Orthopedic Implants
8.1. Introduction
8.2. Joint Replacement
8.2.1. Hip Replacement
8.2.2. Knee Replacement
8.2.3. Shoulder Replacement
8.3. Osteosynthesis
8.3.1. Bone Plates
8.3.2. Bone Screws
8.4. Trauma Fixation
8.4.1. External Fixators
8.4.2. Intramedullary Nails
8.4.3. Plates And Screws
9. Biological Implants Market, by Cardiovascular Implants
9.1. Introduction
9.2. Heart Valves
9.2.1. Mechanical
9.2.2. Tissue
9.3. Stents
9.3.1. Bare Metal
9.3.2. Drug Eluting
9.4. Vascular Grafts
10. Biological Implants Market, by Dental Implants
10.1. Introduction
10.2. Endosseous Implants
10.2.1. Blade Form
10.2.2. Root Form
10.3. Subperiosteal Implants
10.4. Zygomatic Implants
11. Biological Implants Market, by Spinal Implants
11.1. Introduction
11.2. Disc Replacement
11.3. Spinal Fixation
11.3.1. Plates
11.3.2. Screws And Rods
11.4. Spinal Fusion Devices
11.4.1. Bone Graft Substitutes
11.4.2. Cages
12. Biological Implants Market, by Neurological Implants
12.1. Introduction
12.2. Deep Brain Stimulators
12.2.1. Adaptive
12.2.2. Fixed Rate
12.3. Spinal Cord Stimulators
12.3.1. Paddle
12.3.2. Percutaneous
12.4. Vagal Nerve Stimulators
13. Biological Implants Market, by Ocular Implants
13.1. Introduction
13.2. Intraocular Lenses
13.2.1. Monofocal
13.2.2. Multifocal
13.2.3. Toric
13.3. Retinal Implants
13.3.1. Epiretinal
13.3.2. Subretinal
14. Americas Biological Implants Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biological Implants Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biological Implants Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. Medtronic plc
17.3.3. Stryker Corporation
17.3.4. Zimmer Biomet Holdings, Inc.
17.3.5. Abbott Laboratories
17.3.6. Boston Scientific Corporation
17.3.7. Edwards Lifesciences Corporation
17.3.8. Smith & Nephew plc
17.3.9. Becton, Dickinson and Company
17.3.10. Globus Medical, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOLOGICAL IMPLANTS MARKET MULTI-CURRENCY
FIGURE 2. BIOLOGICAL IMPLANTS MARKET MULTI-LANGUAGE
FIGURE 3. BIOLOGICAL IMPLANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOLOGICAL IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SHOULDER REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BONE PLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BONE SCREWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BARE METAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BLADE FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ROOT FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ZYGOMATIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DISC REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SCREWS AND RODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ADAPTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY FIXED RATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PADDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY VAGAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MONOFOCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MULTIFOCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TORIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY EPIRETINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SUBRETINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 106. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 107. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 108. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 109. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 110. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 111. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 112. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 113. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 114. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 115. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 116. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 117. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 118. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 119. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 120. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 121. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 122. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 123. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 126. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 128. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 130. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 132. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 135. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 141. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 215. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 217. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 218. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 219. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 221. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 222. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 223. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 224. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 225. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 226. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 227. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 228. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 229. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 230. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 231. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 232. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 234. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 235. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 236. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 237. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 238. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 239. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 240. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 241. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 242. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 243. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 244. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 245. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 246. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 247. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 249. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 250. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 269. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 270. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 271. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 272. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 273. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 274. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 275. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 276. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 277. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 278. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 279. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 280. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 281. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 282. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 283. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 284. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 285. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 286. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 287. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 289. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 291. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 292. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 293. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 294. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 295. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 296. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 297. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 298. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 299. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 300. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 301. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 302. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 303. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 304. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSSEOUS IMPLANTS, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FIXATION, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY OCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY RETINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 324. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY OSTEOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 326. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION, 2018-2030 (USD MILLION)
TABLE 327. SAUDI AR

Companies Mentioned

The companies profiled in this Biological Implants market report include:
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Smith & Nephew plc
  • Becton, Dickinson and Company
  • Globus Medical, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 49.91 Billion
Forecasted Market Value ( USD ) by 2030 $ 131.13 Billion
Compound Annual Growth Rate21.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bio-Implants Market Size, Share, Trends and Forecast by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region, 2025-2033 - Product Image

Bio-Implants Market Size, Share, Trends and Forecast by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region, 2025-2033

  • Report
  • 133 Pages
  • Global
From
Bio-implant Market by Product Type, Material, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Bio-implant Market by Product Type, Material, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Bio-Implants Market Report 2025 - Product Image

Bio-Implants Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bio Implants Market Report and Forecast 2024-2032 - Product Image

Bio Implants Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Bioimplants - Global Strategic Business Report - Product Image

Bioimplants - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.